Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States.
| Revenue (Most Recent Fiscal Year) | $802.80M |
| Net Income (Most Recent Fiscal Year) | $53.51M |
| PE Ratio (Current Year Earnings Estimate) | 61.17 |
| PE Ratio (Trailing 12 Months) | 63.71 |
| PEG Ratio (Long Term Growth Estimate) | 2.12 |
| Price to Sales Ratio (Trailing 12 Months) | 4.85 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 6.47 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 80.92 |
| Pre-Tax Margin (Trailing 12 Months) | 8.57% |
| Net Margin (Trailing 12 Months) | 7.92% |
| Return on Equity (Trailing 12 Months) | 10.00% |
| Return on Assets (Trailing 12 Months) | 8.68% |
| Current Ratio (Most Recent Fiscal Quarter) | 9.01 |
| Quick Ratio (Most Recent Fiscal Quarter) | 7.44 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | 1.68 |
| Book Value per Share (Most Recent Fiscal Quarter) | $21.56 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.10 |
| Earnings per Share (Most Recent Fiscal Year) | $1.75 |
| Diluted Earnings per Share (Trailing 12 Months) | $2.17 |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 29.49M |
| Free Float | 28.29M |
| Market Capitalization | $4.08B |
| Average Volume (Last 20 Days) | 0.53M |
| Beta (Past 60 Months) | 1.39 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 4.10% |
| Percentage Held By Institutions (Latest 13F Reports) | 94.91% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |